Layered double hydroxide (LDH) nanoparticles synthesized with Mg2+, Al3+, and Dy3+ cations were intercalated with folate ions; this ion increased the interlayer space and allowed passive targeting. This expanded structure retains additional gallate ions in the layers. The folate/gallate-containing compound (Mg/Al/Dy-FG) showed a crystalline structure typical of LDH as evidenced by X-ray diffraction and infrared spectroscopy analyses. The toxicity of the Mg/Al/Dy-FG compound against HT29 cells leads to a cell viability between 20 and 40% with doses from 12.5 to 50 μg/mL in a period between 24 and 72 h. Such viability is close to that produced by gallic acid itself. Furthermore, when the treatment is conducted on healthy cells, Hek293, at the same doses and exposure times, the toxicity effect is significantly reduced since viability remains above 80%; therefore, the administration of gallate through the folate-intercalated LDH nanoparticles reduces the viability of cancer cells while avoiding the damage to healthy cells. Then these nanoscale particles could be promising in the treatment of cancer.
Layered double hydroxide Drug targeting Cytotoxicity Gallate Nanomedicine Biomaterials
This is a preview of subscription content, log in to check access.
A.A.V.G. thanks CONACYT scholarship.
Financial support is acknowledged from CONACyT through the project 256690 (Fondo Sectorial de Investigación para la Educación).
Compliance with ethical standards
Conflict of interest
The authors declare no competing conflict of interest.
Agarwal C, Tyagi A, Agarwal R (2006) Gallic acid causes inactivating phosphorylation of cdc25A/cdc25C-cdc2 via ATM-Chk2 activation, leading to cell cycle arrest, and induces apoptosis in human prostate carcinomaDU145 cells. Mol Cancer Ther 5(12):3294–3303CrossRefGoogle Scholar
Arratia-Quijada J, Sánchez Jiménez C, Gurinov A, Pérez Centeno A, Ceja Andrade I, Carbajal Arízaga GG (2016) Dysprosium-containing layered double hydroxides nanoparticles intercalated with biologically active species as an approach for theranostic systems. Mater Sci Eng B 203:7–12CrossRefGoogle Scholar
Arratia-Quijada J, Rivas-fuentes S, Parra-Saavedra KJ, Macías-Lamas AM, Carbajal-Arizaga GG (2016b) Layered double hydroxide as a vehicle to increase toxicity of gallate ions against adenocarcinoma cells. Molecules 21(928):1–8Google Scholar
Bhattacharjee S (2016) DLS and zeta potential – what they are and what they are not? J Control Release 235:337–351CrossRefGoogle Scholar
Carbajal-Arízaga GG, Salvio Mangrich A, Wypych F (2008) Cu2+ ions as a paramagnetic probe to study the surface chemical modification process of layered double hydroxides and hydroxide salts with nitrate and carboxylate anions. J Colloid Interface Sci 320:238–244CrossRefGoogle Scholar
Choy J-H, Jung J-S, Oh J-M, Park M, Jeong J, Kang Y-K et al (2004) Layered double hydroxide as an efficient drug reservoir for folate derivatives. Biomaterials 25(15):3059–3064CrossRefGoogle Scholar
Depan D, Shah J, Misra RDK (2011) Controlled release of drug from folate-decorated and graphene mediated drug delivery system: synthesis, loading efficiency, and drug release response. Mater Sci Eng C 31(7):1305–1312CrossRefGoogle Scholar
Gun’ko YK, Brougham DF. (2009) Magnetic nanomaterials as MRI contrast agents. In: Kumar C, editor. Magnetic nanomaterials. 1st ed. New Jersey, USA: WILEY-VCH Verlag GmbH & Co.; p. 119–35Google Scholar
Hsu J, Kao S, Ou T, Chen Y, Li Y, Wang C. (2011) Gallic acid induces G2 / M phase arrest of breast cancer cell MCF-7 through stabilization of p27 Kip1 attributed to disruption of p27 Kip1 / Skp2 complex.;59:1996–2003Google Scholar
Inoue M, Suzuki R, Sakaguchi N, Li Z, Takeda T, Ogihara Y, et al. (1995) Selective induction of cell death in cancer cells by gallic acid.;18(11):1526–30Google Scholar
Kang X, Li C, Cheng Z, Ma P, Hou Z, Lin J (2014) Lanthanide-doped hollow nanomaterials as theranostic agents. Wiley Interdiscip Rev Nanomed Nanobiotechnol 6(1):80–101CrossRefGoogle Scholar
Kim SY, Oh J-M, Lee JS, Kim T-J, Choy J-H (2008) Gadolinium (III) diethylenetriamine pentaacetic acid/ layered double hydroxide nanohybrid as novel T1-magnetic resonant nanoparticles. J Nanosci Nanotechnol 8(10):5181–5184CrossRefGoogle Scholar
Kong X, Jin L, Wei M, Duan X (2010) Antioxidant drugs intercalated into layered double hydroxide: structure and in vitro release. Appl Clay Sci 49(3):324–329CrossRefGoogle Scholar
Kuthati Y, Kankala RK, Lee C-h (2015) Layered double hydroxide nanoparticles for biomedical applications: current status and recent prospects. Appl Clay Sci 112-113:100–116CrossRefGoogle Scholar
Leamon CP, Low PS (2001) Folate-mediated targeting: from diagnostics to drug and gene delivery. Drug Discov Today 6(1):44–51CrossRefGoogle Scholar
Li D, Zhang YT, Yu M, Guo J, Chaudhary D, Wang CC (2013) Cancer therapy and fluorescence imaging using the active release of doxorubicin from MSPs/Ni-LDH folate targeting nanoparticles. Biomaterials 34(32):7913–7922CrossRefGoogle Scholar
Low PS, Henne WA, Doorneweerd DD (2008) Discovery and development of folic-acid-based receptor targeting for imaging and therapy of cancer and inflammatory diseases. Acc Chem Res 41(1):120–129CrossRefGoogle Scholar
Nakagaki S et al (2016) Recent advances in solid catalysts obtained by metalloporphyrins immobilization on layered new catalytic results. Molecules 21(3):291Google Scholar
Onishi YK, Obayashi SK, Himizu MS (2003) Transepithelial transport of p -coumaric acid and gallic acid in Caco-2 cell monolayers. Biosci Biotechnol Biochem 67(11):2317–2324CrossRefGoogle Scholar
Pauling L (1929) The principles determining the structure of complex ionic crystals. J Am Chem Soc 51(4):1010–1026CrossRefGoogle Scholar
Qin L, Wang S, Zhang R, Zhu R, Sun X, Yao S (2008) Two different approaches to synthesizing Mg-Al-layered double hydroxides as folic acid carriers. J Phys Chem Solids 69(11):2779–2784CrossRefGoogle Scholar
Silion M, Hritcu D, Lisa G, Popa MI (2012) New hybrid materials based on layered double hydroxides and antioxidant compounds. Preparation, characterization and release kinetic studies. J Porous Mater 19:267–276CrossRefGoogle Scholar
Stefanakis D, Ghanotakis DF (2010) Synthesis and characterization of gadolinium nanostructured materials with potential applications in magnetic resonance imaging, neutron-capture therapy and targeted drug delivery. J Nanopart Res 12(4):1285–1297CrossRefGoogle Scholar
Sudimack J, Lee RJ (2000) Targeted drug delivery via the folate receptor. Adv Drug Deliv Rev 41(2):147–162CrossRefGoogle Scholar
Wang S, Low PS (1998) Folate-mediated targeting of antineoplastic drugs, imaging agents, and nucleic acids to cancer cells. J Control Release 53(1–3):39–48CrossRefGoogle Scholar
Wang L, Li B, Chen C, Jia L (2010) Structural characterization and related properties of the stearate anions intercalated Ni–Al hydrotalcite-like compound prepared by the microwave crystallization. J Alloys Compd 508(2):426–432CrossRefGoogle Scholar
Wang L, Xing H, Zhang S, Ren Q, Pan L, Zhang K, et al. (2013) A Gd-doped Mg-Al-LDH/Au nanocomposite for CT/MR bimodal imagings and simultaneous drug delivery. Biomaterials; 34(13):3390–3401. Available from: https://doi.org/10.1016/j.biomaterials.2013.01.070
Xu ZP, Kurniawan ND, Bartlett PF, Lu GQ (2007) Enhancement of relaxivity rates of Gd-DTPA complexes by intercalation into layered double hydroxide nanoparticles. Chem Eur J 13(10):2824–2830CrossRefGoogle Scholar
Yeganeh Ghotbi M, bin Hussein MZ (2010) Gallate–Zn–Al-layered double hydroxide as an intercalated compound with new controlled release formulation of anticarcinogenic agent. J Phys Chem Solids 71(11):1565–1570CrossRefGoogle Scholar
Zhang Y, Evans JRG (2012) Alignment of layered double hydroxide platelets. Colloids Surf A Physicochem Eng Asp 408:71–78CrossRefGoogle Scholar
Zielhuis SW, Nijsen JFW, Seppenwoolde JH, Zonnenberg BA, Bakker CJG, Hennink WE et al (2005) Lanthanide bearing microparticulate systems for multi-modality imaging and targeted therapy of cancer. Curr Med Chem Anticancer Agents 5:303–313CrossRefGoogle Scholar
Zwicke GL, Ali Mansoori G, Jeffery CJ (2012) Utilizing the folate receptor for active targeting of cancer nanotherapeutics. Nano Rev 3(1):18496CrossRefGoogle Scholar